Business hours

Monday - Friday 8am to 4:30pm
After hours or weekends if required by protocol

Horario de oficina

Lunes - Vienes 8 am a 4.30 pm
Fuera de horario o fines de semana si lo requiere el protocolo


(305) 456-9062


Clinical studies

Atopic Dermatitis

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy ofTapinarof Cream 1% in Subjects with Atopic Dermatitis.

Age group: 6 to 17 years old
Gender: Male or Female
Duration: Up to 52 weeks approximately
Compensation: Up to: $4.050

About this study:
This 48-week, Phase 3, OL-LTE study is being conducted as part of a clinical development program to evaluate the long-term safety and continued efficacy of tapinarof cream, 1% for the treatment of Atopic Dermatitis in children and adults.

Who can participate?
Participants must be Male and female ages 2 years to < 18 years at the time of consent with clinical diagnosis of Atopic Dermatitis.Atopic Dermatitis present for at least 6 months for ages 6 years old and above or 3 months for ages 2 to 5 years old, confirmed by prior medical documentation and/or according to the subject/caregiver report.

Where is the study taking place?
The study is being conducted at our facility in Palmetto Medical Plaza.


Current Clinical Research Study Request

Enter your full legal name

Clinical studies



Monday - Friday 9am to 4:30pm
After hours or weekends if required by protocol

Main Line

(305) 456-9141

24 Hour Phone

786) 214-1433


Palmetto Medical Plaza 7100 West 20th Avenue, Suite 411 Hialeah, FL 33016

Email Us